Home > Search: Caffeine Tablets

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Caffeine Tablets All Topic Areas 1 - 10 of 401  more >> Caffeine Caffeine Tablets Caffedrine Enerjets NoDoz Vivarin Caffeine Addiction Carbinoxamine and Pseudoephedrine Tablets Coldec D Tablets Palgic D Tablets Articles 1 - 1 of 1 Statement on Generic Oxycodone Hydrochloride Extended Release Tablets The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine... U.S. Food and Drug Administration News 1 - 5 of 288  more >> Coke announces new labels revealing amount of caffeine per serving The Earth Times - Fri, 23 Feb 2007 12:22 EST Coca-Cola to Put Caffeine Content Information on U.S. Labels New York Times - Thu, 22 Feb 2007 03:39 EST Actavis Launches Alprazolam ER Tablets In The U.S. MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST Vital Signs: Childbirth: Cutting Caffeine Not Found to Affect Birth Weight New York Times - Mon, 12 Feb 2007 10:21 EST Caffeine May Prevent Heart Disease Death In Elderly MedicalNewsToday - Tue, 27 Feb 2007 03:00 EST Clinical Trials 1 - 5 of 140  more >> Assessment and Treatment of Caffeine Dependence ClinicalTrials.gov Identifier: NCT00338195 - Recruiting Self-Identified Problematic Caffeine Use; DSM-IV Substance Dependence as Applied to Caffeine Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting Pain PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets ClinicalTrials.gov Identifier: NCT00491998 - Recruiting Parkinson's Disease Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting Pain Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans? ClinicalTrials.gov Identifier: NCT00205166 - Recruiting Coronary Artery Disease

GoldBambooTM Your Integrative Health and Wellness Resource November 25, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.